Cargando…
Author Correction: Oral immunotherapy combined with omalizumab for high–risk cow’s milk allergy: a randomized controlled trial
Autores principales: | Takahashi, Masaya, Soejima, Kazuhiko, Taniuchi, Shoichiro, Hatano, Yasuko, Yamanouchi, Sohsaku, Ishikawa, Hideki, Irahara, Makoto, Sasaki, Youhei, Kido, Hiroshi, Kaneko, Kazunari |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6102225/ https://www.ncbi.nlm.nih.gov/pubmed/30127456 http://dx.doi.org/10.1038/s41598-018-30919-3 |
Ejemplares similares
-
Oral immunotherapy combined with omalizumab for high–risk cow’s milk allergy: a randomized controlled trial
por: Takahashi, Masaya, et al.
Publicado: (2017) -
Successful desensitization in a boy with severe cow’s milk allergy by a combination therapy using omalizumab and rush oral immunotherapy
por: Takahashi, Masaya, et al.
Publicado: (2015) -
Two-weeks-sustained unresponsiveness by oral immunotherapy using microwave heated cow’s milk for children with cow’s milk allergy
por: Takahashi, Masaya, et al.
Publicado: (2016) -
Erratum to: Two-weeks-sustained unresponsiveness by oral immunotherapy using microwave heated cow’s milk for children with cow’s milk allergy
por: Takahashi, Masaya, et al.
Publicado: (2016) -
Immunotherapy for cow's milk allergy
por: Taniuchi, Shoichiro, et al.
Publicado: (2017)